184 related articles for article (PubMed ID: 35532120)
21. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
[TBL] [Abstract][Full Text] [Related]
22. SEMA3F prevents metastasis of colorectal cancer by PI3K-AKT-dependent down-regulation of the ASCL2-CXCR4 axis.
Zhou ZH; Rao J; Yang J; Wu F; Tan J; Xu SL; Ding Y; Zhan N; Hu XG; Cui YH; Zhang X; Dong W; Liu XD; Bian XW
J Pathol; 2015 Aug; 236(4):467-78. PubMed ID: 25866254
[TBL] [Abstract][Full Text] [Related]
23. A CXCR4-targeted nanocarrier achieves highly selective tumor uptake in diffuse large B-cell lymphoma mouse models.
Falgàs A; Pallarès V; Unzueta U; Céspedes MV; Arroyo-Solera I; Moreno MJ; Sierra J; Gallardo A; Mangues MA; Vázquez E; Villaverde A; Mangues R; Casanova I
Haematologica; 2020 Mar; 105(3):741-753. PubMed ID: 31248974
[TBL] [Abstract][Full Text] [Related]
24. Hydrogen inhibits endometrial cancer growth via a ROS/NLRP3/caspase-1/GSDMD-mediated pyroptotic pathway.
Yang Y; Liu PY; Bao W; Chen SJ; Wu FS; Zhu PY
BMC Cancer; 2020 Jan; 20(1):28. PubMed ID: 31924176
[TBL] [Abstract][Full Text] [Related]
25. Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in CXCR4
Sala R; Sánchez-García L; Serna N; Céspedes MV; Casanova I; Roldán M; Sánchez-Chardi A; Unzueta U; Vázquez E; Mangues R; Villaverde A
Acta Biomater; 2019 Nov; 99():426-432. PubMed ID: 31494293
[TBL] [Abstract][Full Text] [Related]
26. The response of PIK3CA/KRAS-mutant colorectal cancer stem-like cells to RGD-peptide FraC produced by the strawberry anemone: A promising water-soluble peptide-based inhibitor of metastasis-driver gene CXCR4, stem cell regulatory genes and self-renewal.
Sarkhosh-Inanlou R; Imani M; Sam MR
Biomed Pharmacother; 2020 Dec; 132():110807. PubMed ID: 33068939
[TBL] [Abstract][Full Text] [Related]
27. Pan-cancer analysis reveals the expression, genetic alteration and prognosis of pyroptosis key gene GSDMD.
Qiu S; Hu Y; Dong S
Int Immunopharmacol; 2021 Dec; 101(Pt A):108270. PubMed ID: 34700129
[TBL] [Abstract][Full Text] [Related]
28. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4.
Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS
Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333
[TBL] [Abstract][Full Text] [Related]
29. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
Khare T; Bissonnette M; Khare S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
[TBL] [Abstract][Full Text] [Related]
30. A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse model.
Pallarès V; Unzueta U; Falgàs A; Aviñó A; Núñez Y; García-León A; Sánchez-García L; Serna N; Gallardo A; Alba-Castellón L; Álamo P; Sierra J; Cedó L; Eritja R; Villaverde A; Vázquez E; Casanova I; Mangues R
Biomaterials; 2022 Jan; 280():121258. PubMed ID: 34847435
[TBL] [Abstract][Full Text] [Related]
31. IRF2 contributes to myocardial infarction via regulation of GSDMD induced pyroptosis.
Li Y; Wang Y; Guo H; Wu Q; Hu Y
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34878155
[TBL] [Abstract][Full Text] [Related]
32. Nodal-induced L1CAM/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids.
Cave DD; Hernando-Momblona X; Sevillano M; Minchiotti G; Lonardo E
Theranostics; 2021; 11(12):5686-5699. PubMed ID: 33897875
[No Abstract] [Full Text] [Related]
33. Ubiquitinated gasdermin D mediates arsenic-induced pyroptosis and hepatic insulin resistance in rat liver.
Zhu Y; Zhang J; Yao X; Qiu T; Jiang L; Wang N; Shi Y; Wu C; Yuan W; Yang G; Liu X; Bai J; Men L; Sun X
Food Chem Toxicol; 2022 Feb; 160():112771. PubMed ID: 34920032
[TBL] [Abstract][Full Text] [Related]
34. An Apoptotic Caspase Network Safeguards Cell Death Induction in Pyroptotic Macrophages.
de Vasconcelos NM; Van Opdenbosch N; Van Gorp H; Martín-Pérez R; Zecchin A; Vandenabeele P; Lamkanfi M
Cell Rep; 2020 Jul; 32(4):107959. PubMed ID: 32726624
[TBL] [Abstract][Full Text] [Related]
35. CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation.
Brand S; Dambacher J; Beigel F; Olszak T; Diebold J; Otte JM; Göke B; Eichhorst ST
Exp Cell Res; 2005 Oct; 310(1):117-30. PubMed ID: 16125170
[TBL] [Abstract][Full Text] [Related]
36. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
[TBL] [Abstract][Full Text] [Related]
37. Selective CXCR4
Díaz R; Pallarès V; Cano-Garrido O; Serna N; Sánchez-García L; Falgàs A; Pesarrodona M; Unzueta U; Sánchez-Chardi A; Sánchez JM; Casanova I; Vázquez E; Mangues R; Villaverde A
Small; 2018 Jun; 14(26):e1800665. PubMed ID: 29845742
[TBL] [Abstract][Full Text] [Related]
38. Thioredoxin-1 inhibits amyloid-β
Jia J; Zhang X; Xu G; Zeng X; Li L
Mol Biol Rep; 2022 May; 49(5):3445-3452. PubMed ID: 35072836
[TBL] [Abstract][Full Text] [Related]
39. CXCR3 expression in colorectal cancer cells enhanced invasion through preventing CXCR4 internalization.
Jin J; Zhang Z; Wang H; Zhan Y; Li G; Yang H; Fei Z; Xu Y; Li W
Exp Cell Res; 2018 Oct; 371(1):162-174. PubMed ID: 30092218
[TBL] [Abstract][Full Text] [Related]
40. Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4
Rioja-Blanco E; Arroyo-Solera I; Álamo P; Casanova I; Gallardo A; Unzueta U; Serna N; Sánchez-García L; Quer M; Villaverde A; Vázquez E; Mangues R; Alba-Castellón L; León X
Acta Pharm Sin B; 2022 May; 12(5):2578-2591. PubMed ID: 35646535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
